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OBJECTIVE: The aim of this study was to analyze the effect of glucosamine sulfate on the tibial epiphyseal disk of the
ovariectomized rats.
METHODS: After ovariectomy (OVx), 28 female rats were randomly divided into 4 experimental groups with 7 animals each,
treated as follows: OVx 21—vehicle (NaCl 0.9%) 0.5 mL/day) for 21 days; OVx GS21—230 mg/kg/day glucosamine sulphate
for 21 days; OVx 45—treated with NaCl 0.9% as above for 45 days; and OVx GS45—230 mg/kg/day glucosamine sulphate for 45
days. Seven intact animals in the proestrous phase were used as controls (CG). Upon treatment completion, the animals were
sacrificed and the left knee joint was dissected and prepared for histological analysis.
RESULTS: The percentage of remaining cartilage in new bone of the CG; that found in THE OVx GS45 group was significantly
less than that of the OVx 21, OVx GS21, and OVx 45 groups. The percentage of trabecular bone in proestrous animals was the
highest. The OVx GS45 group showed higher values compared with the other ovariectomized groups. These results were paralleled
by the findings regarding the cells of the proliferative zone, since the CG had the highest values, and the values of the OVx GS45
group were greater than those of the OVx 21, OVx GS21, and OVx 45 groups.
CONCLUSION: Our studies suggested that glucosamine may stimulate tibial cartilage and bone growth after ovariectomy in
rats.
KEY-WORDS: Glucosamine. Epiphyseal disk. Tibia. Ovariectomy. Female rats.
INTRODUCTION
Osteoporosis is a serious problem for postmenopausal
and elderly women, and it is known that estrogen deficiency
plays a causative role in its development.1 Estrogen can act
directly or indirectly on osteoblasts and osteoclasts through
estrogen receptor-mediated mechanisms,2 such as inhibi-
tion of production of bone-resorptive cytokines from bone
marrow stromal cells,3 direct inhibition of the activity of
osteoclasts,4 enhancement of osteoblast proliferation, and
stimulation of secretion of bone matrix proteins by
osteoblasts.5 In fact, a definite anabolic effect on bone for-
mation can be found in estrogen-deficient animal models.6,7
Not surprisingly, estrogen therapy has been widely accepted
as an effective treatment in postmenopausal women for pre-
venting reduction of the bone mineral density.8 However,
prolonged estrogen replacement therapies have proved to
increase the risks of breast and uterine cancer.9,10 In addi-
tion, bone mineral density may decline after discontinua-
tion of short-term menopausal hormone therapy (MHT),
which would increase the fracture risks. Also, past-MHT
users are osteopenic just as are non-users.11 Therefore, al-
ternative osteoporosis-targeted treatments with milder ad-
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verse reactions would be highly desirable.
Glucosamine is a nontoxic, bioavailable, naturally oc-
curring component of the cartilage matrix.12 Glucosamine
has been shown to have a number of favorable effects on
cartilage metabolism in vitro, including a reduction in ar-
ticular cartilage breakdown and stimulation of synthesis of
matrix components by chondrocytes.13 Given orally to
osteoarthritic patients, glucosamine has been shown to de-
crease joint pain and improve mobility.14 Unfortunately, the
available information regarding the effect of such treatment
on bone morphology is rather limited. It has been found
that the administration of glucosamine produces a signifi-
cant reduction in left hind paw swelling following onset
of arthritis in rats along with a lesser degree of edema and
new bone formation.15 In addition, the Canadian
Multicenter Osteoporosis Study showed that the weighted
values for bone mass density (BMD) of men using
glucosamine were lower than those of men not using it.16
The opposite was seen in women, since those who were
under glucosamine treatment had a higher mean BMD than
their untreated counterparts.16 Also, a few studies have
shown that a polymer of N-acetylglucosamine and
glucosamine may induce the cellular response for bone re-
generation and increase the cellular growth and prolifera-
tion in vitro.17,18
In the present study, female rats were used as an ani-
mal model for investigating the effects of an oral
glucosamine sulphate preparation on the joint bone mor-
phology of estrogen-deprived rats.
MATERIALS AND METHODS
Animals and treatments
The local institution’s guidelines for the care and use
of the animals were followed; these guidelines comply with
those of the Canadian Council on Animal Care19 and the
NIH’s Institutional Animal Care and Use Committee Guide-
book. The experimental protocol was approved by the lo-
cal Ethics Committee on Animal Experimentation. Female
adult, virgin, EPM-1 Wistar rats were selected after 3 regu-
lar consecutive estrous cycles and kept under specific patho-
gen-free conditions at a constant day/night cycle (lights on
07:00-19:00). Animals were fed Purina® pelleted rat food
and tap water ad libitum.
Seven animals in the proestrous phase were assigned
to the control group (CG), and 28 rats after being ovariec-
tomized (OVx) were randomly divided into 4 experimen-
tal groups with 7 animals each: OVx 21—treated with ve-
hicle (NaCl 0.9%) for 21 days; OVx GS21—treated with
glucosamine sulphate (GS) (Zodiac Tecnofarma,
Pindamonhangaba, Brazil, 230 mg/kg, ip) for 21 days; OVx
45—treated with vehicle (NaCl 0.9%) for 45 days; and OVx
GS45—treated with glucosamine sulphate (230 mg/kg, ip)
for 45 days. The glucosamine sulfate and vehicle treatments
were started on the 21st day after ovariectomy.
At the end of treatment, all animals were sacrificed un-
der anesthesia (xylazine 20 mg/kg plus ketamine 100 mg/
kg, ip); then, the left tibia was dissected and fixed in buff-
ered formaldehyde 10% at room temperature for 24 hours.
After treatment with 7% ethylenediaminetetraacetic acid
(EDTA), the decalcified joint matrix was embedded in par-
affin and cut into 5 µm histological sections that were
stained with hematoxylin and eosin.
Histomorphometric analysis
After the histological procedures, morphometric meas-
urements were performed using digitalized images obtained
directly from the light microscope via a videocamera and
stored in magnetic medium. Measurements were automati-
cally performed using the Imagelab-Softium® software (São
Paulo, Brazil). The analyses were performed in 10
microscopical fields per histological section from a total
of 4 histological sections per animal. The normal
chondrocytes of the epiphyseal disk in non ovariectomized
female rats (CG) were organized in well-defined regions:
resting cartilage zone, proliferative zone, hypertrophic zone,
calcified zone, and ossification zone.
The newly formed bone was defined as the measured
osseous structure from the end of epiphyseal disk to the
Weibel reticule. In this area, we calculated the remaining
cartilage (resting state), the trabecular bone, and the bone
marrow (Figure 1). In addition, cell counting was performed
Figure 1 - Photomicrography showing the Weibel reticule under the
epiphyseal disk of a female rat in the proestrous. The thick lines were
representative of noncounted lines. The circle shows 1 of the 36 points of
intersection for measurements. B, trabecular bone; C, remaining cartilage;
M, bone marrow. Hemotoxylin-eosin (100x). Bar = 10 µm.
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at the proliferative zone of the epiphyseal disk (30 columns
per animal). In order to avoid some overcounting due to
the ‘reticular extremity effect’ reported by Gundersen,20 2
lines of each reticular extremity were not considered in the
calculations.21
Statistical analysis
Data from the morphometric analyses are reported as
mean ± standard deviation (SD). The histomorphometrical
results (remaining cartilage, bone marrow, trabecular bone,
and proliferative zone) were analyzed by the Barlett´s test
and 1-way analysis of variance followed by Tukey´s post
hoc test, with the level of significance set at P < .05. The
data of every parameter were confirmed to follow a
Gaussian distribution.
RESULTS
Histomorphology
The ovariectomized groups treated with vehicle (OVx
21 and OVx 45) showed an increased resting cartilage zone
and a significant shortening of the proliferative zone. This
change was more intensive in the animals treated with ve-
hicle for 45 days than in the other groups. In fact, the pro-
liferative zone had a low number of disorganized cuboid
cells. In the glucosamine-treated groups, the treatment for
21 days did not affect the resting cartilage and prolifera-
tive zones. The histomorphology of this group was similar
to OVx 21 (vehicle treatment), but it was worse than the
nonovariectomized rat group. The animals treated during
45 days with glucosamine showed an improvement in the
proliferative zone with respect to the other ovariectomized
animals; however, this increase was lower than that seen
in proestrous animals.
In the glucosamine-treated groups, the treatment for 21
days did not affect the resting cartilage and proliferative
zones. The histomorphology of this group was similar to
OVx 21. The animals treated during 45 days with
glucosamine showed an improvement in the proliferative
zone with respect to the other ovariectomized animals;
however, this increase was lower than that seen in
proestrous animals (Figure 2).
Histomorphometric results
Table 1 shows the values of the histomorphological data
of the remaining cartilage, trabecular bone, bone marrow,
and the cell number in the proliferative zone of the tibial
epiphyseal disk. The percentage of remaining cartilage in
new bone of the CG was the lowest (13.6 ± 1.5, P < .01).
Results from the OVx GS45 group (17.8 ± 2.8, P < .05)
were significantly lower than those from the OVx 21 (21.5
± 2.1) , OVx GS21 (20.7 ± 1.1), and OVx 45 (22.7 ± 1.3)
groups. No difference was found among the groups regard-
ing the tibial bone marrow. The percentage of trabecular
bone in proestrous phase animals (CG) had the highest val-
ues (28.1 ± 2.4, P < .01), and that for the OVx GS45 group
(26.9 ± 2.2, P < .05) was higher than the other ovariect-
omized groups. The cells of the proliferative zone presented
similar results: CG had the highest values (195.5 ± 11.9,
P < .01), and the OVx GS45 group (149.5 ± 4.2, P < .05)
Table 1 - Histomorphometrical data of knee joint bone preparations using a female rat model of osteoporosis.
Animal groups
CG OVx 21 OVx GS21 OVx 45 OVx GS45
Remaining cartilage (%) 13.6 ± 1.5* 21.5 ± 2.1 20.7 ± 1.1 22.7 ± 1.3 17.8 ± 2.8**
Bone marrow (%) 58.2 ± 5.8 57.4 ± 4.7 55.1 ± 4.8 57.0 ± 7.5 55.3 ± 4.7
Trabecular bone (%) 28.1 ± 2.4* 21.1 ± 1.9 24.3 ± 2.8 20.3 ± 1.1 26.9 ± 2.2**
Proliferative zone (mean of cells in 250 µm2) 195.5 ± 11.9* 95.4 ± 21.2 105.8 ± 4.7 89.3 ± 12.2 149.5 ± 4.2**
*P < .01 compared with other groups; **P < .05 compared with OVx 21, OVx GS21, and OVx 45.
Figure 2 - Photomicrography of rat tibial epiphyseal disk showing the
remaining cartilage and the proliferative zone of each group: CG (saline-
treated, intact, proestrus); OVx 21 (control OVx, 21 days saline); OVx GS21
(OVx, 21 days glucosamine 230 mg/kg OVx 45 (control OVx, 45 days
saline), and OVx GS45 (OVx, 45 days glucosamine 230 mg/kg).
Hemotoxylin-eosin; OVx = animals used 21 days after bilateral ovariectomy
(400x). Bar = 10 µm.
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presented values significantly higher than those found in
the OVx 21 (95.4 ± 21.2), OVx GS21 (105.8 ± 4.7), and
OVx 45 (89.3 ± 12.2) groups.
DISCUSSION
After menopause, the reduction in bone mass is a mat-
ter of great medical concern. Hormone therapy is used for
preventing osteoporosis-related fracture.19 However, large
clinical trials, such as HERS and WHI, showed that post-
menopausal women orally treated for long periods with
conjugated equine estrogens (0.625 mg/day) associated with
medroxyprogesterone (2.5 mg/day) were at a relative risk
of developing breast cancer and cardiovascular disease.22
Consequently, the number of hormone therapy prescriptions
actually decreased after those studies were published.23
Therefore, it has been realized that new approaches for
maintain the bone mass in postmenopausal women are
needed. Herein, our data suggest that glucosamine sulphate
may affect the bone mass of ovariectomized rats. It must
be considered, however, that the doses of glucosamine used
with our animals were higher (8 times) than those used in
humans, mostly because of the species-specific differences
in the metabolic rates.24 Further studies are necessary to
evaluate the effect of different doses of glucosamine for
the same period with respect to a similar action on the rat
tibial epiphyseal disk.
Ovariectomy is a factor that may determine a decrease
in bone growth and deleterious changes in epiphyseal disks.
These bone alterations are similar to those found in senile
rats.25 The reason for these phenomena is the reduction of
the cell mass in proliferative zones and disorganization of
the bone matrix.26 Our results conceivably suggest that the
bone matrix of epiphyseal disks may be a target for the
glucosamine sulphate effects. However, this effect may oc-
cur after a prolonged period of estrogen level decrease. This
fact may explain the reason for not finding a difference be-
tween the glucosamine-treated and nontreated rats after 21
days after ovariectomy.
In clinical trials, the administration of glucosamine has
produced a beneficial change in the osteoarthritis, demon-
strating a chondroprotective effect that results in a signifi-
cant delay in the progression of the disease.24,27-29 Accord-
ingly, glucosamine-treated patients presented better bone
mass with regard to untreated postmenopausal patients.29
The expanded bone mass would be due to the fact that those
patients are more physically active more due to the im-
provements in inflammatory processes and pain.28
Our results confirm findings by other authors that
glucosamine had beneficial effects in rats on the tibial sur-
face, which was the structure selected for analysis in this
study. Those authors suggested that glucosamine may act
on the bone matrix.30,31 In accordance with this view, in
vitro studies have shown that glucosamine inhibits the ef-
fects of interleukin-1, although some authors state that the
inhibiting dose is greater than the maximum serum level
of glucosamine (absorption limit).32 Perhaps, glucosamine
at normal tissue levels acts rather by stimulating the pro-
duction of matrix components than by inhibiting the effects
of interleukin-133. However, further studies are necessary
to investigate the real mechanism of glucosamine on the
rat bone and remaining cartilage after ovariectomy.
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RESUMO
Maganhin CC, Correa O, Gomes RCT, Simões R, Baracat
EC, Soares-Jr JM. Efeitos da terapia de reposição hormonal
estroprogestativa sobre o sistema de coagulação e de
fibrinólise em mulheres na pós-menopausa. Clinics.
2007;62(5):607-12.
OBJETIVO: O alvo deste estudo foi analisar o efeito do
sulfato de glicosamina no disco epifisário da tíbia em ratas
ooforectomizadas.
MÉTODOS: Após a ooforectomia (OVx), 28 ratas foram
aleatoriamente divididas em 4 grupos experimentais de 7
animais cada, tratados da seguinte maneira: OVx 21 – veí-
culo (0,5ml de NaCl 0.9% ip uma vez ao dia) por 21 dias;
OVx GS21 – 230 mg/kg peso corporal por dia de sulfato
de glicosamina, 21 dias; OVx 45 – tratados com NaCl 0.9%
igual ao grupo OVx 21, por 45 dias; e OVx GS45 – 230
mg/kg peso corporal por dia com sulfato de glicosamina,
45 dias. Sete animais intactos, na fase de proestro, foram
usados como controle (CG). Ao completar o tratamento,
os animais foram sacrificados e a articulação do joelho es-
querdo foi dissecada e preparada para análise histológica.
RESULTADOS: A porcentagem de cartilagem remanes-
cente no novo osso do CG foi a menor. Os achados no gru-
po OVx GS45 foi significantemente menor do que no gru-
po OVx 21, OVx GS21 e OVx 45. A porcentagem de osso
trabecular nos animais em pró-estro foi a maior. O grupo
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OVx GS45 mostrou valores maiores em relação aos outros
grupos ooforectomizados. Esses resultados foram corres-
pondentes aos achados em relação às células da zona
proliferativa, desde que o CG teve os maiores valores e os
valores do grupo OVx GS45 foram superiores aos dos gru-
pos OVx 21, OVx GS21 e OVx 45.
CONCLUSÃO: Nossos estudos sugerem que a glicosamina
pode estimular o crescimento da cartilagem e do osso tibial
após a ooforectomia em ratas.
UNITERMOS: Glicosamina. Disco epifisário. Tíbia. Oofo-
rectomia. Ratas.
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